Home/Filings/4/0001144204-17-034639
4//SEC Filing

Alliqua BioMedical, Inc. 4

Accession 0001144204-17-034639

CIK 0001054274operating

Filed

Jun 27, 8:00 PM ET

Accepted

Jun 28, 4:30 PM ET

Size

5.4 KB

Accession

0001144204-17-034639

Insider Transaction Report

Form 4
Period: 2017-06-28
POSNER BRIAN M
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2017-06-28+100,000547,254 total
Footnotes (1)
  • [F1]Represents a restricted stock award that is subject to forfeiture until vested. The award vests fully on the date, if any, the Issuer files financial statements with the SEC on Form 10-K or Form 10-Q that report a positive adjusted EBITDA for the Company for two consecutive fiscal quarters, subject to the Reporting Person's continued service through the applicable vesting date and the terms and conditions of the Alliqua BioMedical, Inc. 2014 Long-Term Incentive Plan and that certain restricted stock award agreement by and between the Issuer and the Reporting Person, effective as of June 28, 2017.

Issuer

Alliqua BioMedical, Inc.

CIK 0001054274

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001054274

Filing Metadata

Form type
4
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 4:30 PM ET
Size
5.4 KB